Patent · US Active

Dual release oral tablet compositions of dexlansoprazole

US8753682B2 · kind B2 · utility

0Cited by
1References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 23, 2013
Grant dateJun 17, 2014
Priority date
Expiry dateSep 23, 2033

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Dual release oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.